Core Points - The company has revised its 2023 Restricted Stock Incentive Plan, which aims to establish a long-term incentive mechanism to attract and retain talent while aligning the interests of shareholders, the company, and core team members [2][9][23] - The total number of restricted stocks to be granted is not to exceed 7 million shares, accounting for approximately 1.50% of the company's total share capital [2][13] - The initial grant will consist of 5.6 million shares, representing 1.20% of the total share capital, with 80% of the total grant allocated to this initial portion [2][13] - The grant price for the initial restricted stock is set at 7.80 yuan per share, which is below the average trading price prior to the announcement [3][20] Summary by Sections Incentive Plan Overview - The incentive plan is based on various laws and regulations, including the Company Law and Securities Law of the People's Republic of China [1][2] - The plan is designed to motivate key personnel, including directors and senior management, while excluding independent directors and supervisors [5][12] Stock Grant Details - The plan allows for a total of 700,000 shares to be granted, with 560,000 shares for the initial grant and 140,000 shares reserved for future allocation [2][13] - The total number of shares involved in all active incentive plans does not exceed 20% of the company's total share capital [3][15] Grant Conditions - The plan stipulates that the grant will be effective for a maximum of 76 months from the date of the first grant [4][16] - The plan includes performance-based conditions for the vesting of shares, with specific revenue growth targets set for the years 2024 to 2026 [23][25] Management and Oversight - The shareholders' meeting is the highest authority for approving the plan, while the board of directors is responsible for its execution [9][10] - The supervisory board and independent directors will oversee the plan to ensure it aligns with the company's long-term development and does not harm shareholder interests [9][10] Performance Assessment - The performance assessment will include both company-level and individual-level evaluations, with specific metrics for revenue growth and profit margin improvements [25][26] - The plan aims to ensure that the performance indicators are reasonable and scientifically set, taking into account market conditions and company strategy [25][26]

Core Viewpoint - The company has revised its 2023 Restricted Stock Incentive Plan, aiming to establish a long-term incentive mechanism to attract and retain talent while aligning the interests of shareholders, the company, and core team members [8][9]. Group 1: Incentive Plan Overview - The incentive plan involves granting a total of up to 7 million restricted stocks, accounting for approximately 1.50% of the company's total share capital of 466.822836 million shares [2][13]. - The initial grant consists of 5.6 million shares, representing 1.20% of the total share capital, with 80% of the total grant allocated to this initial portion [2][13]. - The plan is valid for a maximum of 76 months from the date of the first grant [4][16]. Group 2: Eligibility and Conditions - Eligible participants include 21 individuals, such as directors, senior management, and core technical personnel, excluding supervisors and independent directors [5][12]. - The initial grant price is set at 7.80 yuan per share, which is below the average trading price prior to the announcement [3][20]. - The plan stipulates that participants must meet specific performance and tenure conditions to qualify for stock vesting [22][23]. Group 3: Performance Targets - The performance assessment for the initial grant will be based on annual revenue growth rates, with a minimum increase of 10% for 2024 compared to 2023 [23][25]. - The performance targets for subsequent years will escalate, with specific growth rates set for 2025 and 2026 [25][26]. Group 4: Adjustments and Accounting - The plan includes provisions for adjusting the number of restricted stocks and grant prices in response to corporate actions such as stock splits or capital increases [29]. - The company will use the Black-Scholes model to determine the fair value of the restricted stocks for accounting purposes [28].

北京首都在线科技股份有限公司 （2025 年 8 月） 北京首都在线科技股份有限公司（以下简称"公司"）为进一步完善公司法人治 理结构，健全公司的激励约束机制，形成良好均衡的价值分配体系，充分调动核心团 队的积极性，使其更诚信勤勉地开展工作，以保证公司业绩稳步提升，确保公司发展 战略和经营目标的实现，公司拟实施 2025 年限制性股票激励计划（以下简称"股权激 励计划"）。 为保证股权激励计划的顺利实施，现根据《中华人民共和国公司法》《中华人民 共和国证券法》《上市公司股权激励管理办法》《深圳证券交易所创业板股票上市规 则》《深圳证券交易所创业板上市公司自律监管指南第 1 号——业务办理》等有关法 律、法规和规范性文件以及《北京首都在线科技股份有限公司章程》、公司股权激励 计划的相关规定，并结合公司的实际情况，特制定本办法。 一、考核目的 进一步完善公司法人治理结构，建立和完善公司激励约束机制，保证公司股权激 励计划的顺利实施，并在最大程度上发挥股权激励的作用，进而确保公司发展战略和 经营目标的实现。 二、考核原则 考核评价必须坚持公正、公开、公平的原则，严格按照本办法和考核对象的业绩 进行评价，以实现股权激 ...

Core Viewpoint - The company has adjusted the grant price of its 2024 restricted stock incentive plan due to the implementation of equity distribution, lowering the price from 15.39 CNY per share to 14.69 CNY per share [1][4]. Group 1: Approval Process - The company held the fourth board meeting and the fourth supervisory board meeting on August 20, 2025, where the adjustment of the grant price was approved [1]. - The supervisory board confirmed that the individuals included in the incentive plan met the necessary legal and regulatory conditions [2]. Group 2: Reasons for Price Adjustment - The adjustment was made following a cash dividend distribution totaling 145,582,452 CNY (including tax), with no capital reserve conversion or stock dividends [2][3]. - The company distributed a cash dividend of 6.50 CNY per 10 shares (including tax) for the year 2024, amounting to a total of 378,514,375.20 CNY (including tax) [3]. Group 3: Adjustment Methodology - The adjustment formula for the grant price is defined as P = P0 - V, where P0 is the original grant price, V is the dividend per share, and P is the adjusted grant price [3]. - The adjusted grant price calculation is as follows: 15.39 CNY - 0.25 CNY - 0.45 CNY = 14.69 CNY per share [4]. Group 4: Impact of Adjustment - The adjustment complies with relevant laws and regulations and will not materially affect the company's financial status or operational results [5]. - The adjustment has been authorized within the scope of the board's powers and does not require further shareholder approval [5]. Group 5: Legal Opinion - The legal opinion from Beijing Zhonglun (Shenzhen) Law Firm confirms that the adjustment of the grant price has obtained necessary approvals and complies with relevant regulations [5].

证券代码：688004 证券简称：博汇科技 公告编号：2025-027 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 北京市博汇科技股份有限公司（以下简称"公司"）第四届监事会第十三次 会议于 2025 年 8 月 20 日上午 10:00 在公司会议室召开。本次会议的通知于 2025 年 8 月 8 日通过邮件方式送达全体监事。本次会议应出席监事 3 人，实际出席监 事 3 人，会议由监事会主席邰志强先生主持。会议的召开符合《中华人民共和国 公司法》和《公司章程》的规定。经与会监事认真审议并表决，一致通过了如下 事项： 二、监事会会议审议情况 （一）审议通过《关于 <公司 ensp="ensp" 年半年度报告="年半年度报告"> 及其摘要的议案》 公司 2025 年半年度报告及摘要的编制和审议程序符合相关法律法规及《公司 章程》等内部规章制度，真实、准确、完整地反映了公司 2025 年半年度的财务状 况和经营成果等事项，不存在任何虚假记载、误导性陈述或重大遗漏。 表决结果：同意 3 票，反对 0 ...

Core Points - The company, Guangzheng Eye Hospital Group Co., Ltd., has announced a supplementary notice regarding the second extraordinary general meeting of shareholders for the year 2025, scheduled for September 4, 2025 [1][2] - The controlling shareholder, Guangzheng Investment Co., Ltd., will submit a temporary proposal to amend the company's articles of association at the upcoming meeting [1][2] - The meeting will allow shareholders to vote either in person or via an online voting platform provided by the Shenzhen Stock Exchange [2][5] Meeting Details - The extraordinary general meeting will take place on September 4, 2025, at 15:00, with online voting available from 9:15 to 11:30 on the same day [2][3] - Shareholders must register to attend the meeting, with specific procedures outlined for both individual and corporate shareholders [3][4] - Voting will be conducted through a single method, either in-person or online, and duplicate votes will be disregarded, with the first valid vote counted [3][6] Proposals for Discussion - The agenda includes a proposal for the repurchase and cancellation of part of the restricted stock incentive plan from 2023, which has already been approved by the company's supervisory board [3][8] - Another proposal involves changing the company's business type and amending the articles of association, which will also be presented for approval [8]

Core Viewpoint - The legal opinion letter addresses the invalidation of part of the 2023 restricted stock incentive plan of Beijing Bohui Technology Co., Ltd. regarding unvested restricted stocks that were authorized but not yet vested [1][10]. Group 1: Legal Framework and Approval - The legal opinion is based on various laws and regulations, including the Company Law, Securities Law, and relevant management measures for stock incentives [2][3]. - The company has obtained necessary approvals and authorizations for the invalidation of the unvested restricted stocks, as per the resolutions and independent opinions from the board and supervisory committee [4][10]. Group 2: Reasons for Invalidation - The invalidation of the restricted stocks is due to the departure of three incentive targets, which results in 91,650 shares becoming unvested and thus invalidated [10][11]. - Additionally, the company did not meet performance assessment targets, leading to the invalidation of a total of 482,925 shares, including 391,275 shares from the initial grant and 91,650 shares from the reserved grant [11][12]. Group 3: Conclusion - The legal opinion concludes that the invalidation of the unvested restricted stocks complies with relevant laws and regulations, and the necessary approvals have been obtained [12].

安徽天禾律师事务所 法律意见书 安徽天禾律师事务所 关于 安徽安科生物工程（集团）股份有限公司 第三期限制性股票激励计划 回购注销部分限制性股票相关事项 之 法律意见书 致：安徽安科生物工程（集团）股份有限公司 安徽天禾律师事务所（以下简称"本所"）接受安徽安科生物工程（集团） 股份有限公司（以下简称"安科生物"或"公司"）的委托，担任安科生物实 施第三期限制性股票激励计划相关事宜（以下简称"本次股权激励计划"或"激 励计划"）的专项法律顾问。本所律师根据《中华人民共和国公司法》（以下 简称《公司法》）《上市公司股权激励管理办法》（证监会 148 号令）（以下 简称《管理办法》）《深圳证券交易所创业板股票上市规则》（以下简称《上 市规则》）《深圳证券交易所创业板上市公司自律监管指南第 1 号——业务办 理》等有关法律及其他有关法律、法规、规范性文件，以及《安徽安科生物工 程（集团）股份有限公司第三期限制性股票激励计划（草案）》（以下简称《激 励计划》）和《安徽安科生物工程（集团）股份有限公司公司章程》（以下简 称《公司章程》）的相关规定，对本次股权激励计划所涉及的回购注销部分限 制性股票相关事项出具本法律意见 ...

Core Viewpoint - The company announced the cancellation of 574,575 restricted stocks that were granted but not vested under the 2023 restricted stock incentive plan due to certain conditions not being met [5][6][7]. Group 1: Decision Process and Disclosure - The company held board and supervisory meetings to review and approve the relevant proposals regarding the 2023 restricted stock incentive plan [1][2]. - Independent directors provided independent opinions on the incentive plan, confirming the legitimacy of the granted stocks [3][5]. Group 2: Cancellation Details - A total of 91,650 shares were canceled due to three initial grantees leaving the company, which disqualified them from the incentive plan [5]. - Additionally, 482,925 shares were canceled because the company's 2024 revenue did not meet the performance assessment criteria set in the incentive plan [6]. Group 3: Impact on the Company - The cancellation of these restricted stocks is not expected to have a substantial impact on the company's financial status or operational results [6][7]. - The management team remains committed to fulfilling their responsibilities and creating value for shareholders [6]. Group 4: Committee Opinions - The Compensation and Assessment Committee and the Supervisory Committee both agreed that the cancellation of the unvested restricted stocks complies with relevant laws and regulations, and does not harm the interests of shareholders [7]. Group 5: Legal Opinion - The legal opinion concluded that the company has obtained the necessary approvals for the cancellation and that the action aligns with applicable laws and the provisions of the incentive plan [7].

证券代码：688655 证券简称：迅捷兴 公告编号：2025-056 深圳市迅捷兴科技股份有限公司 关于向 2025 年限制性股票激励计划激励对象 授予预留部分限制性股票的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 ? 限制性股票预留授予日：2025 年 8 月 21 日 ? 限制性股票预留授予数量：13.36 万股，约占目前公司已发行股份总数 ? 股权激励方式：第二类限制性股票 《深圳市迅捷兴科技股份有限公司 2025 年限制性股票激励计划（草案）》 （以下简称"《激励计划（草案）》"）规定的限制性股票授予条件已经成就， 根据深圳市迅捷兴科技股份有限公司（以下简称"公司"）2025 年第一次临时 股东大会授权，公司于 2025 年 8 月 21 日召开的第四届董事会薪酬与考核委员 会第一次会议、第四届董事会第二次会议，审议通过了《关于向 2025 年限制性 股票激励计划激励对象授予预留部分限制性股票的议案》，确定公司 2025 年限 制性股票激励计划（以下简称"本次激励计划"）的预留授予日为 202 ...